CLINICAL TRIALS PROFILE FOR TNKASE
✉ Email this page to a colleague
All Clinical Trials for TNKASE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00121446 ↗ | Which Therapy for Acute Heart Attacks? (The WEST Study) | Completed | Eli Lilly and Company | Phase 2/Phase 3 | 2003-07-01 | In the setting of acute myocardial infarction (heart attacks), the principle objective of the WEST Study is to compare the impact on clinical outcomes of 3 different treatment strategies. The first is using medical (drug) therapy alone with standard care. The second strategy is identical medical (drug) therapy as the first group combined with early heart catheterization (within 24 hours) for angiography and if required, intervention. The third treatment strategy is direct admission (within 3 hrs) to the heart catheterization lab for angioplasty. WEST patients will be enrolled at first medical contact (using emergency medical services, e.g. ambulance) if possible or through Emergency Departments in participating health care facilities. |
| NCT00121446 ↗ | Which Therapy for Acute Heart Attacks? (The WEST Study) | Completed | Hoffmann-La Roche | Phase 2/Phase 3 | 2003-07-01 | In the setting of acute myocardial infarction (heart attacks), the principle objective of the WEST Study is to compare the impact on clinical outcomes of 3 different treatment strategies. The first is using medical (drug) therapy alone with standard care. The second strategy is identical medical (drug) therapy as the first group combined with early heart catheterization (within 24 hours) for angiography and if required, intervention. The third treatment strategy is direct admission (within 3 hrs) to the heart catheterization lab for angioplasty. WEST patients will be enrolled at first medical contact (using emergency medical services, e.g. ambulance) if possible or through Emergency Departments in participating health care facilities. |
| NCT00121446 ↗ | Which Therapy for Acute Heart Attacks? (The WEST Study) | Completed | Sanofi | Phase 2/Phase 3 | 2003-07-01 | In the setting of acute myocardial infarction (heart attacks), the principle objective of the WEST Study is to compare the impact on clinical outcomes of 3 different treatment strategies. The first is using medical (drug) therapy alone with standard care. The second strategy is identical medical (drug) therapy as the first group combined with early heart catheterization (within 24 hours) for angiography and if required, intervention. The third treatment strategy is direct admission (within 3 hrs) to the heart catheterization lab for angioplasty. WEST patients will be enrolled at first medical contact (using emergency medical services, e.g. ambulance) if possible or through Emergency Departments in participating health care facilities. |
| NCT00121446 ↗ | Which Therapy for Acute Heart Attacks? (The WEST Study) | Completed | University of Alberta | Phase 2/Phase 3 | 2003-07-01 | In the setting of acute myocardial infarction (heart attacks), the principle objective of the WEST Study is to compare the impact on clinical outcomes of 3 different treatment strategies. The first is using medical (drug) therapy alone with standard care. The second strategy is identical medical (drug) therapy as the first group combined with early heart catheterization (within 24 hours) for angiography and if required, intervention. The third treatment strategy is direct admission (within 3 hrs) to the heart catheterization lab for angioplasty. WEST patients will be enrolled at first medical contact (using emergency medical services, e.g. ambulance) if possible or through Emergency Departments in participating health care facilities. |
| NCT01580618 ↗ | Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy | Terminated | Genentech, Inc. | Phase 2/Phase 3 | 2008-01-01 | The objective of the study is to determine the safety and efficacy of TNK infusion for the treatment of loculated pleural effusions in patients with known malignancy compared to normal saline infusion. |
| NCT01580618 ↗ | Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy | Terminated | Kaiser Permanente | Phase 2/Phase 3 | 2008-01-01 | The objective of the study is to determine the safety and efficacy of TNK infusion for the treatment of loculated pleural effusions in patients with known malignancy compared to normal saline infusion. |
| NCT02180204 ↗ | Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN) | Withdrawn | Reza Behrouz, DO | Phase 2/Phase 3 | 2015-01-01 | This is a double-blind parallel arm randomized trial aimed to assess efficacy and safety of intravenous Tenecteplase compared to intravenous Alteplase in eligible patients who present with symptoms of acute ischemic stroke within 3 to 4.5 hours from onset. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TNKASE
Condition Name
Clinical Trial Locations for TNKASE
Trials by Country
Clinical Trial Progress for TNKASE
Clinical Trial Phase
Clinical Trial Sponsors for TNKASE
Sponsor Name
